Orchid Pharma

26
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
862.85
-2.3 (-0.27%)
BSENSE

Dec 05

BSE+NSE Vol: 9.86 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
819.00
665.00
559.00
450.00
483.00
599.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
819.00
665.00
559.00
450.00
483.00
599.00
Expenditure (Ex Depriciation)
Stock Adjustments
-43.00
-21.00
-27.00
-17.00
-18.00
26.00
Raw Materials Consumed
528.00
406.00
340.00
245.00
221.00
263.00
Power & Fuel Cost
62.00
61.00
52.00
39.00
47.00
48.00
Employee Cost
69.00
65.00
63.00
67.00
74.00
82.00
Operating Expenses
32.00
29.00
26.00
24.00
41.00
41.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
23.00
14.00
22.00
13.00
8.00
10.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
5.00
6.00
7.00
3.00
22.00
94.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
708.00
581.00
504.00
399.00
453.00
611.00
Operating Profit (PBDIT) excl Other Income
111.00
84.00
54.00
50.00
30.00
-11.00
Other Income
30.00
19.00
9.00
15.00
24.00
16.00
Operating Profit (PBDIT)
141.00
103.00
63.00
65.00
54.00
5.00
Interest
16.00
32.00
33.00
52.00
6.00
6.00
Profit before Depriciation and Tax
125.00
70.00
30.00
13.00
48.00
-1.00
Depreciation
33.00
54.00
87.00
108.00
117.00
129.00
Profit Before Taxation & Exceptional Items
91.00
16.00
-56.00
-95.00
-69.00
-131.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
91.00
55.00
-56.00
-95.00
-69.00
69.00
Provision for Tax
-3.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
95.00
55.00
-56.00
-95.00
-69.00
69.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
-2,268.00
-2,314.00
-2,313.00
-2,197.00
-1,869.00
-1,940.00
Profit Available for appropriations
-2,176.00
-2,261.00
-2,374.00
-2,293.00
-1,939.00
-1,870.00
Appropriations
-2,176.00
-2,261.00
-2,374.00
-2,293.00
-1,939.00
-1,870.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
19.06
11.35
-0.48
-28.55
-14.75
7.80
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 12.52% vs 23.05% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 11.58% vs 31.75% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -10.62% vs -49.22% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 12.38% vs 71.50% in Mar 2024

Compare Profit and Loss Results of Orchid Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
819.00
0
819.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
819.00
0
819.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-43.00
0
-43.00
0%
Raw Materials Consumed
528.00
0
528.00
0%
Power & Fuel Cost
62.00
0
62.00
0%
Employee Cost
69.00
0
69.00
0%
Operating Expenses
32.00
0
32.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
23.00
0
23.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
5.00
0
5.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
708.00
0
708.00
0%
Operating Profit (PBDIT) excl Other Income
111.00
0.00
111.00
0%
Other Income
30.00
0
30.00
0%
Operating Profit (PBDIT)
141.00
0
141.00
0%
Interest
16.00
0
16.00
0%
Profit before Depriciation and Tax
125.00
0
125.00
0%
Depreciation
33.00
0
33.00
0%
Profit Before Taxation & Exceptional Items
91.00
0
91.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
91.00
0
91.00
0%
Provision for Tax
-3.00
0
-3.00
0%
Profit After Tax
95.00
0
95.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
-2,268.00
0
-2,268.00
0%
Profit Available for appropriations
-2,176.00
0
-2,176.00
0%
Appropriations
-2,176.00
0
-2,176.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
19.06
0
19.06
0%
Profit And Loss - Net Sales
Net Sales 921.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.52% vs 23.05% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 123.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.58% vs 31.75% in Mar 2024

Profit And Loss - Interest
Interest 14.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -10.62% vs -49.22% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 106.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.38% vs 71.50% in Mar 2024